AorTech International PLC | Balance Sheet

Fiscal year is April-March. All values GBP Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
385.10
242.50
218.50
91.20
421.30
Total Accounts Receivable
238.70
468.20
29.20
114.40
134.00
Inventories
27.60
-
-
-
-
Other Current Assets
1.80
28.30
139.80
199.10
-
Total Current Assets
653.20
739.00
387.50
404.70
555.30
Long-Term Note Receivable
179.90
-
-
-
-
Intangible Assets
1,116.30
1,041.40
951.10
730.90
525.40
Total Assets
1,949.40
1,780.40
1,338.60
1,135.60
1,080.70
Accounts Payable
45.60
-
8.30
6.40
2.90
Other Current Liabilities
138.00
129.30
106.50
75.20
64.90
Total Current Liabilities
183.50
129.30
114.80
81.60
67.70
Other Liabilities
115.80
35.70
-
-
-
Total Liabilities
299.30
165.00
114.80
81.60
67.70
Common Equity (Total)
1,650.10
1,615.40
1,223.80
1,054.00
1,013.00
Total Shareholders' Equity
1,650.10
1,615.40
1,223.80
1,054.00
1,013.00
Total Equity
1,650.10
1,615.40
1,223.80
1,054.00
1,013.00
Liabilities & Shareholders' Equity
1,949.40
1,780.40
1,338.60
1,135.60
1,080.70

About AorTech International

View Profile
Address
Springfield House
Weybridge Surrey KT13 9LZ
United Kingdom
Employees -
Website http://www.aortech.net
Updated 07/08/2019
AorTech International Plc is a holding company, which engages in the commercialization of biomedical polymer technology, components, and medical devices. It manufactures biostable and implantable polymers under the Elast-Eon and ECSil brands. The company was founded by James Gordon Wright and Edward McDaid in 1992 and is headquartered in Weybridge, the United Kingdom.